Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction

• Status: Completed
• Trial end date: 2007-12-12
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate and compare the safety and efficacy of various doses of the aromatase inhibitor (anastrozole) versus clomiphene citrate in stimulating follicular growth and ovulation in infertile women with ovulatory dysfunction.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: EMD Serono
• Treatments: Anastrozole; Citric Acid; Clomiphene; Enclomiphene; Sodium Citrate; Zuclomiphene

Criteria

Inclusion Criteria:

• Aged 18-40 years

• Ovulatory dysfunction characterized by irregular and/or extended cycles

• Non-smoker

Exclusion Criteria:

• No previous gonadotropin treatment

• No more than 6 previous clomiphene treatment cycles